|
Core Support for Cancer Center
|
5P30CA013330-37
|
$3,927,232
|
GOLDMAN, Israel
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Mismatch repair in V region mutation and isotype switching
|
2R01CA102705-06A1
|
$324,645
|
SCHARFF, MATTHEW
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Roles of Glycoslyation in Notch Signaling
|
5R01CA095022-08
|
$422,605
|
STANLEY, PAMELA
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Role of the BCL 6 Proto Oncogene in B Cell Lymphomas
|
5R01CA085573-09
|
$357,886
|
Ye, Bihui
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
Optimize RNA-aptamer for Biomarker Molecule CD30
|
1R43CA141842-01
|
$123,605
|
Yang, Xianbin
|
AM BIOTECHNOLOGIES, LLC
|
|
Radiation Therapy Oncology Group
|
2U10CA021661-33
|
$12,534,580
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Targeted Gene Therapy for Lymphoma
|
5R01CA113454-04
|
$263,186
|
SMITH, BRUCE
|
AUBURN UNIVERSITY AT AUBURN
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
SPORE in Lymphoma
|
3P50CA126752-03S1
|
$371,941
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
5P50CA126752-03
|
$2,266,618
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of PML nuclear body proteins for establishment of EBV latent infection
|
5R01CA124309-04
|
$258,530
|
Ling, Paul
|
BAYLOR COLLEGE OF MEDICINE
|
|
Post-Transcriptional Regulation of Polycistronic MicroRNAs in Mammalian Cells
|
4R00CA131474-03
|
$249,000
|
Neilson, Joel
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S1
|
$117,279
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-03S2
|
$245,600
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-03
|
$1,515,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanism and Consequences of Telomere Dysfunction
|
5R01CA133249-02
|
$318,513
|
Songyang, Zhou
|
BAYLOR COLLEGE OF MEDICINE
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-11
|
$130,866
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Expression and Function of Tob in T Lymphocytes
|
5R01CA104596-05
|
$318,352
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Reconstitution of T cell immunity after UCB transplantation: The role of Treg
|
5R21CA123855-02
|
$390,741
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
BIDMC Research Training Grant in Cancer Radiology
|
5T32CA059367-15
|
$99,433
|
CLOUSE, MELVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Multistep Lymphomagenesis/Tumorigenesis in Transgenic Mice: Protein Kinase Ck2
|
5R01CA071796-12
|
$275,767
|
SELDIN, DAVID
|
BOSTON MEDICAL CENTER
|
|
Inhibitors of Epstein-Barr Virus Nuclear Protein 1 Mediated Latent Infection
|
1R01CA131354-01A1
|
$365,892
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Epstein-Barr Virus Nuclear Proteins in B Cell Growth Transformation
|
5R01CA047006-22
|
$560,086
|
KIEFF, ELLIOTT
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
SPORE in Skin Cancer
|
5P50CA093683-07
|
$2,300,000
|
KUPPER, THOMAS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Pathogenesis of Epstein-Barr Virus Infection
|
5R01CA068051-14
|
$417,501
|
WANG, FREDERICK
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Inflammation-regulated microRNA in B cell lymphoma
|
5R01CA135531-02
|
$358,457
|
RICKERT, ROBERT
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA030199-28S1
|
$118,420
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA030199-28S2
|
$3,387,817
|
VUORI, KRISTIINA
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
|
The role of miR-155 in cell cycle regulation and tumorigenesis
|
1F32CA139883-01
|
$47,210
|
So, Alex
|
CALIFORNIA INSTITUTE OF TECHNOLOGY
|
|
Carle Cancer Center Community Clinical Oncology Program
|
5U10CA035195-26
|
$841,092
|
ROWLAND, KENDRITH
|
CARLE CLINIC ASSOCIATION, P C
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-35
|
$417,370
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Non-natural Nucleoside Inhibitors of DNA Polymerases
|
5R01CA118408-05
|
$229,214
|
BERDIS, ANTHONY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
|
5U01CA062502-16
|
$772,307
|
DOWLATI, AFSHIN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S2
|
$70,196
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-20S3
|
$99,890
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-20
|
$4,865,452
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
T Cell Immunity in Endemic Burkitt Lymphoma
|
5R01CA134051-02
|
$493,967
|
MOORMANN, ANN
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cedar Rapids Oncology Project
|
5U10CA052352-20
|
$446,062
|
WIESENFELD, MARTIN
|
CEDAR RAPIDS ONCOLOGY PROJECT
|
|
Identification of Hematopoietic Stem and Progenitor Cell Viability Genes
|
1R43CA141848-01
|
$249,465
|
Bonneau, Kyle
|
CELLECTA, INC.
|
|
RhoH GTPase in Hematopoiesis and Cancer
|
5R01CA113969-05
|
$318,664
|
WILLIAMS, DAVID
|
CHILDREN'S HOSPITAL BOSTON
|
|
Rac GTPases as Targets in Lymphomagenesis
|
5R01CA125658-03
|
$285,000
|
ZHENG, YI
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
|
Molecular Pathways in Suppression and Development of T Lineage Lymphomas
|
5R01CA125195-03
|
$312,550
|
BASSING, CRAIG
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
USE OF mTOR INHIBITORS IN B CELL LEUKEMIA
|
5R01CA102646-05
|
$320,964
|
GRUPP, STEPHAN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
|
Delaware/Christiana Care CCOP
|
5U10CA045418-23
|
$1,282,700
|
Grubbs, Stephen
|
CHRISTIANA CARE HEALTH SERVICES, INC.
|
|
Research and Mentoring on Energetic Factors and Cancer: Established Investigator
|
1K05CA136967-01A1
|
$131,592
|
BERNSTEIN, LESLIE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Lymphoma SPORE
|
3P50CA107399-05S1
|
$1,079,832
|
forman, stephen
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
City of Hope Southwest Oncology Group Clinical Trials
|
5U10CA046368-22
|
$332,211
|
MORTIMER, JOANNE
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Phase I Molecular and Clincal Pharmacodynamic Trials
|
5U01CA062505-16
|
$608,527
|
NEWMAN, EDWARD
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
Ultrahigh sensitive, personalized monitoring of lymphoma relapse using blood spec
|
1R21CA138359-01
|
$219,120
|
YEN, YUN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|